Q Interline A/S

Q Interline A/S has a price-to-book ratio of 12.08 and a price-to-tangible-book ratio of 12.08, indicating a premium valuation relative to its book value. The company's enterprise value to EBITDA is negative at -4.39, reflecting a loss-making position, while the enterprise value to revenue of 2.07 suggests a relatively low valuation based on revenue. The company's return on equity is -3.27% and return on assets is -0.72%, both significantly below the industry median for Industrial Machinery & Equipment, which typically sees ROE and ROA in the 10-15% and 5-10% ranges, respectively. This underperformance is driven by a net loss of DKK 17.73 million and an operating loss of DKK 16.42 million. Q Interline A/S generates revenue primarily from the dairy, feed, food, and agricultural industries, with additional exposure to pharma and chemical sectors in the Nordics. The company's revenue concentration is not disclosed, but its geographic exposure is primarily in the Nordic region. The lack of detailed segment reporting limits the ability to assess revenue diversification. The company's revenue growth trajectory is uncertain, with no disclosed revenue growth rate. However, the operating cash flow of -DKK 12.29 million and free cash flow of -DKK 16.81 million indicate a cash flow challenge. The capital expenditure of -DKK 455,000 suggests minimal investment in new capacity, which may limit future growth. The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. The debt-to-equity ratio of 1.47 indicates a leveraged capital structure, and the current ratio of 1.2 suggests limited short-term liquidity. The dilution risk is assessed as low, with no near-term pressure from share issuance. Recent events include the company's 2024 Q1 financial results, which show a continued net loss and negative cash flows. No significant regulatory or operational events have been disclosed in the latest filings, but the company's financial performance remains a concern.